{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:12:06Z","timestamp":1789229526622,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007833","name":"Hamad Medical Corporation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007833","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-026-06985-5","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:51:31Z","timestamp":1777409491000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Placental hormones, IGF-1, and early-life growth: endocrine links between birth size and infant metabolic programming\u2014a systematic review"],"prefix":"10.1007","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9585-9461","authenticated-orcid":false,"given":"Ashraf T.","family":"Soliman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawzia","family":"Alyafei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Alaaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayma","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohair","family":"Elsiddig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"issue":"4","key":"6985_CR1","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1152\/physrev.00029.2015","volume":"96","author":"GJ Burton","year":"2016","unstructured":"Burton GJ, Fowden AL, Thornburg KL (2016) Placental origins of chronic disease. Physiol Rev 96(4):1509\u20131565. https:\/\/doi.org\/10.1152\/physrev.00029.2015","journal-title":"Physiol Rev"},{"issue":"Suppl","key":"6985_CR2","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.placenta.2012.05.002","volume":"33","author":"AL Fowden","year":"2012","unstructured":"Fowden AL, Moore T (2012) Maternal\u2013fetal resource allocation: co-operation and conflict. Placenta 33(Suppl):e11\u2013e15. https:\/\/doi.org\/10.1016\/j.placenta.2012.05.002","journal-title":"Placenta"},{"issue":"3","key":"6985_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1515\/JPM.2010.041","volume":"38","author":"AA Baschat","year":"2010","unstructured":"Baschat AA (2010) Fetal growth restriction \u2013 from observation to intervention. J Perinat Med 38(3):239\u2013246. https:\/\/doi.org\/10.1515\/JPM.2010.041","journal-title":"J Perinat Med"},{"issue":"1","key":"6985_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1056\/NEJMra0708473","volume":"359","author":"PD Gluckman","year":"2008","unstructured":"Gluckman PD, Hanson MA, Cooper C et al (2008) Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 359(1):61\u201373. https:\/\/doi.org\/10.1056\/NEJMra0708473","journal-title":"N Engl J Med"},{"issue":"1\u20132","key":"6985_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0378-3782(03)00092-3","volume":"73","author":"AL Fowden","year":"2003","unstructured":"Fowden AL (2003) The role of insulin-like growth factors in fetal growth. Early Hum Dev 73(1\u20132):105\u2013119. https:\/\/doi.org\/10.1016\/S0378-3782(03)00092-3","journal-title":"Early Hum Dev"},{"issue":"1","key":"6985_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0092-8674(05)80085-0","volume":"75","author":"J Baker","year":"1993","unstructured":"Baker J, Liu JP, Robertson EJ et al (1993) Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75(1):73\u201382. https:\/\/doi.org\/10.1016\/S0092-8674(05)80085-0","journal-title":"Cell"},{"issue":"18","key":"6985_CR7","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1056\/NEJM199610313351805","volume":"335","author":"KA Woods","year":"1996","unstructured":"Woods KA, Camacho-H\u00fcbner C, Savage MO et al (1996) Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 335(18):1363\u20131367. https:\/\/doi.org\/10.1056\/NEJM199610313351805","journal-title":"N Engl J Med"},{"issue":"6","key":"6985_CR8","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1210\/er.2009-0028","volume":"31","author":"MO Savage","year":"2010","unstructured":"Savage MO, Burren CP, Rosenfeld RG (2010) The continuum of growth hormone\u2013IGF-I axis defects causing short stature. Endocr Rev 31(6):748\u2013785. https:\/\/doi.org\/10.1210\/er.2009-0028","journal-title":"Endocr Rev"},{"issue":"4","key":"6985_CR9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1515\/JPEM.2000.13.4.343","volume":"13","author":"S Handwerger","year":"2000","unstructured":"Handwerger S, Freemark M (2000) The roles of placental growth hormone and placental lactogen in the regulation of human fetal growth and development. J Pediatr Endocrinol Metab 13(4):343\u2013356. https:\/\/doi.org\/10.1515\/JPEM.2000.13.4.343","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"6985_CR10","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1210\/jc.2003-030892","volume":"89","author":"M Chellakooty","year":"2004","unstructured":"Chellakooty M, Vangsgaard K, Larsen T et al (2004) Longitudinal study of intrauterine growth and the placental GH\u2013IGF-I axis. J Clin Endocrinol Metab 89(1):384\u2013391. https:\/\/doi.org\/10.1210\/jc.2003-030892","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"6985_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029164","volume":"7","author":"MF Higgins","year":"2012","unstructured":"Higgins MF, Russell NE, Lee AJ et al (2012) Maternal and fetal placental growth hormone and IGF axis in type 1 diabetic pregnancy. PLoS ONE 7(3):e29164. https:\/\/doi.org\/10.1371\/journal.pone.0029164","journal-title":"PLoS ONE"},{"issue":"2","key":"6985_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-055257","volume":"12","author":"KL Rassie","year":"2022","unstructured":"Rassie KL, Kusinski LC, Baker PN et al (2022) Lactogenic hormones in relation to maternal metabolic health during pregnancy and postpartum. BMJ Open 12(2):e055257. https:\/\/doi.org\/10.1136\/bmjopen-2021-055257","journal-title":"BMJ Open"},{"issue":"7","key":"6985_CR13","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.3390\/jcm11071889","volume":"11","author":"N Nagano","year":"2022","unstructured":"Nagano N, Fujioka K, Uemura M et al (2022) Percentile-based reference values of umbilical cord blood IGF-1 and neonatal anthropometrics. J Clin Med 11(7):1889. https:\/\/doi.org\/10.3390\/jcm11071889","journal-title":"J Clin Med"},{"issue":"7240","key":"6985_CR14","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1136\/bmj.320.7240.967","volume":"320","author":"KK Ong","year":"2000","unstructured":"Ong KK, Ahmed ML, Emmett PM et al (2000) Association between postnatal catch-up growth and obesity in childhood. BMJ 320(7240):967\u2013971. https:\/\/doi.org\/10.1136\/bmj.320.7240.967","journal-title":"BMJ"},{"issue":"6","key":"6985_CR15","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1203\/00006450-200106000-00012","volume":"49","author":"E Kajantie","year":"2001","unstructured":"Kajantie E, Dunkel L, Turpeinen U et al (2001) IGF-I, IGF-binding protein-3, and insulin in preterm infants. Pediatr Res 49(6):806\u2013811. https:\/\/doi.org\/10.1203\/00006450-200106000-00012","journal-title":"Pediatr Res"},{"issue":"6","key":"6985_CR16","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/apa.13350","volume":"105","author":"A Hellstr\u00f6m","year":"2016","unstructured":"Hellstr\u00f6m A, Ley D, Hansen-Pupp I et al (2016) Insulin-like growth factor 1 has multisystem effects on foetal and preterm infant development. Acta Paediatr 105(6):576\u2013586. https:\/\/doi.org\/10.1111\/apa.13350","journal-title":"Acta Paediatr"},{"issue":"2","key":"6985_CR17","doi-asserted-by":"publisher","first-page":"e367","DOI":"10.1542\/peds.2010-2440","volume":"127","author":"I Hansen-Pupp","year":"2011","unstructured":"Hansen-Pupp I, H\u00f6vel H, Hellstr\u00f6m A et al (2011) Postnatal decrease in circulating IGF-I and impaired brain growth in preterm infants. Pediatrics 127(2):e367\u2013e373. https:\/\/doi.org\/10.1542\/peds.2010-2440","journal-title":"Pediatrics"},{"issue":"Suppl","key":"6985_CR18","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1016\/S0378-3782(01)00211-9","volume":"65","author":"NE Embleton","year":"2001","unstructured":"Embleton NE, Pang N, Cooke RJ (2001) Postnatal malnutrition and growth retardation in preterm infants. Early Hum Dev 65(Suppl):S35\u2013S41. https:\/\/doi.org\/10.1016\/S0378-3782(01)00211-9","journal-title":"Early Hum Dev"},{"issue":"6","key":"6985_CR19","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/s41390-021-01566-8","volume":"91","author":"LS M\u00f6llers","year":"2022","unstructured":"M\u00f6llers LS, Yousuf EI, Hamatschek C et al (2022) Metabolic\u2013endocrine disruption due to preterm birth. Pediatr Res 91(6):1350\u20131360. https:\/\/doi.org\/10.1038\/s41390-021-01566-8","journal-title":"Pediatr Res"},{"key":"6985_CR20","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1210\/jc.2003-030892","volume":"89","author":"M Chellakooty","year":"2004","unstructured":"Chellakooty M, Vangsgaard K, Larsen T et al (2004) Longitudinal study of intrauterine growth and the placental growth hormone\u2013IGF-I axis in maternal circulation. J Clin Endocrinol Metab 89:384\u2013391. https:\/\/doi.org\/10.1210\/jc.2003-030892","journal-title":"J Clin Endocrinol Metab"},{"key":"6985_CR21","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/uog.7727","volume":"36","author":"NG Pedersen","year":"2010","unstructured":"Pedersen NG, Juul A, Christiansen M et al (2010) Maternal serum placental growth hormone is positively associated with fetal growth in the first half of pregnancy. Ultrasound Obstet Gynecol 36:534\u2013541. https:\/\/doi.org\/10.1002\/uog.7727","journal-title":"Ultrasound Obstet Gynecol"},{"key":"6985_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/08977194.2016.1273223","volume":"34","author":"S Liao","year":"2016","unstructured":"Liao S, Vickers MH, Taylor RS et al (2016) Human placental growth hormone is increased at 20 weeks in pregnancies with large-for-gestational-age babies. Growth Factors 34:203\u2013209. https:\/\/doi.org\/10.1080\/08977194.2016.1273223","journal-title":"Growth Factors"},{"key":"6985_CR23","doi-asserted-by":"publisher","unstructured":"Liao S, Vickers MH, Taylor RS et al (2017) Placental growth hormone and IGF axis at 20 weeks in pregnancies complicated by gestational diabetes mellitus. Hormones (Athens) 16:282\u2013290. https:\/\/doi.org\/10.14310\/horm.2002.1747","DOI":"10.14310\/horm.2002.1747"},{"key":"6985_CR24","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1080\/14767050701463571","volume":"20","author":"P Mittal","year":"2007","unstructured":"Mittal P, Espinoza J, Hassan S et al (2007) Placental growth hormone is increased in maternal and fetal serum in preeclampsia. J Matern Fetal Neonatal Med 20:651\u2013659. https:\/\/doi.org\/10.1080\/14767050701463571","journal-title":"J Matern Fetal Neonatal Med"},{"key":"6985_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.preghy.2017.07.148","volume":"10","author":"S Liao","year":"2017","unstructured":"Liao S, Vickers MH, Taylor RS et al (2017) Maternal placental growth hormone and IGF axis in pregnancies complicated by preeclampsia. Pregnancy Hypertens 10:149\u2013154. https:\/\/doi.org\/10.1016\/j.preghy.2017.07.148","journal-title":"Pregnancy Hypertens"},{"key":"6985_CR26","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1055\/s-2002-32138","volume":"34","author":"HD McIntyre","year":"2002","unstructured":"McIntyre HD, Serek R, Crane DI et al (2002) Placental growth hormone is not suppressed by oral glucose loading in normal pregnancy. Horm Metab Res 34:250\u2013253. https:\/\/doi.org\/10.1055\/s-2002-32138","journal-title":"Horm Metab Res"},{"key":"6985_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/uog.10069","volume":"39","author":"S Sifakis","year":"2012","unstructured":"Sifakis S, Akolekar R, Mantas N et al (2012) Maternal serum placental growth hormone at 11\u201313 weeks\u2019 gestation and prediction of small-for-gestational-age neonates. Ultrasound Obstet Gynecol 39:131\u2013136. https:\/\/doi.org\/10.1002\/uog.10069","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"11","key":"6985_CR28","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1210\/jcem.85.11.6998","volume":"85","author":"K Ong","year":"2000","unstructured":"Ong K, Kratzsch J, Kiess W, Costello M, Scott C, Dunger D (2000) Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II\/mannose-6-phosphate receptor in term human infants. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. J Clin Endocrinol Metab 85(11):4266\u20134269. https:\/\/doi.org\/10.1210\/jcem.85.11.6998","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"6985_CR29","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1515\/JPM.2004.139","volume":"32","author":"SM Cooley","year":"2004","unstructured":"Cooley SM, Donnelly JC, Geary MP, Rodeck CH, Hindmarsh PC (2004) Maternal and fetal insulin-like growth factors 1 and 2 (IGF-1, IGF-2) and IGF BP-3, and their relationship to fetal acidosis at delivery. J Perinat Med 32(5):418\u2013421. https:\/\/doi.org\/10.1515\/JPM.2004.139","journal-title":"J Perinat Med"},{"issue":"4","key":"6985_CR30","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4103\/jcn.jcn_32_21","volume":"10","author":"M Mexitalia","year":"2021","unstructured":"Mexitalia M, Utari A, Pratiwi R, Dewantiningrum J (2021) Association of cord blood insulin-like growth factor-1 and leptin levels and changes in fetal weight gain in the third trimester of pregnancy. J Clin Neonatol 10(4):227\u2013232. https:\/\/doi.org\/10.4103\/jcn.jcn_32_21","journal-title":"J Clin Neonatol"},{"issue":"10","key":"6985_CR31","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.4161\/epi.21855","volume":"7","author":"J St-Pierre","year":"2012","unstructured":"St-Pierre J, Hivert MF, Perron P et al (2012) IGF2 DNA methylation is a modulator of newborn\u2019s fetal growth and development. Epigenetics 7(10):1125\u20131132. https:\/\/doi.org\/10.4161\/epi.21855","journal-title":"Epigenetics"},{"issue":"4","key":"6985_CR32","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s10552-012-9932-y","volume":"23","author":"C Hoyo","year":"2012","unstructured":"Hoyo C, Fortner K, Murtha AP et al (2012) Association of cord blood methylation fractions at imprinted insulin-like growth factor 2 (IGF2), plasma IGF2, and birth weight. Cancer Causes Control 23(4):635\u2013645. https:\/\/doi.org\/10.1007\/s10552-012-9932-y","journal-title":"Cancer Causes Control"},{"issue":"5","key":"6985_CR33","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1210\/jc.2011-3296","volume":"97","author":"ZC Luo","year":"2012","unstructured":"Luo ZC, Nuyt AM, Delvin E et al (2012) Maternal and fetal IGF-I and IGF-II levels, fetal growth, and gestational diabetes. J Clin Endocrinol Metab 97(5):1720\u20131728. https:\/\/doi.org\/10.1210\/jc.2011-3296","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"6985_CR34","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1055\/s-0038-1672141","volume":"36","author":"EE Yalinbas","year":"2019","unstructured":"Yalinbas EE, Binay C, Simsek E, Aksit MA (2019) The role of umbilical cord blood concentration of IGF-I, IGF-II, leptin, adiponectin, ghrelin, resistin, and visfatin in fetal growth. Am J Perinatol 36(6):600\u2013608. https:\/\/doi.org\/10.1055\/s-0038-1672141","journal-title":"Am J Perinatol"},{"issue":"4","key":"6985_CR35","first-page":"446","volume":"47","author":"WN Spellacy","year":"1976","unstructured":"Spellacy WN, Buhi WC, Birk SA (1976) Human placental lactogen and intrauterine growth retardation. Obstet Gynecol 47(4):446\u2013448","journal-title":"Obstet Gynecol"},{"issue":"5","key":"6985_CR36","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1210\/jc.2010-0023","volume":"95","author":"J M\u00e4nnik","year":"2010","unstructured":"M\u00e4nnik J, Vaas P, Rull K, Teesalu P, Rebane T, Laan M (2010) Differential expression profile of growth hormone\/chorionic somatomammotropin genes in placenta of small- and large-for-gestational-age newborns. J Clin Endocrinol Metab 95(5):2433\u20132442. https:\/\/doi.org\/10.1210\/jc.2010-0023","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"6985_CR37","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.mce.2012.02.009","volume":"355","author":"J M\u00e4nnik","year":"2012","unstructured":"M\u00e4nnik J, Vaas P, Rull K, Teesalu P, Laan M (2012) Differential placental expression profile of human growth hormone\/chorionic somatomammotropin genes in pregnancies with pre-eclampsia and gestational diabetes mellitus. Mol Cell Endocrinol 355(1):180\u2013187. https:\/\/doi.org\/10.1016\/j.mce.2012.02.009","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"6985_CR38","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1530\/RAF-21-0020","volume":"2","author":"SR Ladyman","year":"2021","unstructured":"Ladyman SR, Larsen CM, Taylor RS, Grattan DR, McCowan LME (2021) Case-control study of prolactin and placental lactogen in SGA pregnancies. Reprod Fertil 2(4):244\u2013250. https:\/\/doi.org\/10.1530\/RAF-21-0020","journal-title":"Reprod Fertil"},{"issue":"24","key":"6985_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232415621","volume":"23","author":"K Rassie","year":"2022","unstructured":"Rassie K, Giri R, Joham AE, Teede H, Mousa A (2022) Human placental lactogen in relation to maternal metabolic health and fetal outcomes: a systematic review and meta-analysis. Int J Mol Sci 23(24):15621. https:\/\/doi.org\/10.3390\/ijms232415621","journal-title":"Int J Mol Sci"},{"key":"6985_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.946539","volume":"13","author":"SM Garay","year":"2022","unstructured":"Garay SM, Sumption LA, John RM (2022) Prenatal health behaviours as predictors of human placental lactogen levels. Front Endocrinol (Lausanne) 13:946539. https:\/\/doi.org\/10.3389\/fendo.2022.946539","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6985_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2020.104655","volume":"116","author":"LA Sumption","year":"2020","unstructured":"Sumption LA, Garay SM, John RM (2020) Low serum placental lactogen at term is associated with postnatal symptoms of depression and anxiety in women delivering female infants. Psychoneuroendocrinology 116:104655. https:\/\/doi.org\/10.1016\/j.psyneuen.2020.104655","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"6985_CR42","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1210\/clinem\/dgaa908","volume":"106","author":"S Ikenoue","year":"2021","unstructured":"Ikenoue S, Waffarn F, Ohashi M et al (2021) Placental corticotrophin-releasing hormone is a modulator of fetal liver blood perfusion. J Clin Endocrinol Metab 106(3):646\u2013653. https:\/\/doi.org\/10.1210\/clinem\/dgaa908","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"6985_CR43","doi-asserted-by":"publisher","first-page":"4979","DOI":"10.1210\/jcem.86.10.7893","volume":"86","author":"CL McTernan","year":"2001","unstructured":"McTernan CL, Draper N, Nicholson H et al (2001) Reduced placental 11beta-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms. J Clin Endocrinol Metab 86(10):4979\u20134983. https:\/\/doi.org\/10.1210\/jcem.86.10.7893","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"6985_CR44","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.placenta.2007.10.010","volume":"29","author":"J Dy","year":"2008","unstructured":"Dy J, Guan H, Sampath-Kumar R, Richardson BS, Yang K (2008) Placental 11beta-hydroxysteroid dehydrogenase type 2 is reduced in pregnancies complicated with idiopathic intrauterine growth restriction: evidence that this is associated with an attenuated ratio of cortisone to cortisol in the umbilical artery. Placenta 29(2):193\u2013200. https:\/\/doi.org\/10.1016\/j.placenta.2007.10.010","journal-title":"Placenta"},{"issue":"6","key":"6985_CR45","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1203\/PDR.0b013e31819e7337","volume":"65","author":"A Tzschoppe","year":"2009","unstructured":"Tzschoppe A, Struwe E, Blessing H et al (2009) Placental 11beta-HSD2 gene expression at birth is inversely correlated with growth velocity in the first year of life after intrauterine growth restriction. Pediatr Res 65(6):647\u2013653. https:\/\/doi.org\/10.1203\/PDR.0b013e31819e7337","journal-title":"Pediatr Res"},{"issue":"5","key":"6985_CR46","doi-asserted-by":"publisher","first-page":"964","DOI":"10.2337\/dc18-2041","volume":"42","author":"L Chen","year":"2019","unstructured":"Chen L, Guilmette J, Luo ZC et al (2019) Placental 11\u03b2-HSD2 and cardiometabolic health indicators in infancy. Diabetes Care 42(5):964\u2013971. https:\/\/doi.org\/10.2337\/dc18-2041","journal-title":"Diabetes Care"},{"key":"6985_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00179","volume":"10","author":"O Baud","year":"2019","unstructured":"Baud O, Berkane N (2019) Hormonal changes associated with intra-uterine growth restriction: impact on the developing brain and future neurodevelopment. Front Endocrinol (Lausanne) 10:179. https:\/\/doi.org\/10.3389\/fendo.2019.00179","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"6985_CR48","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/ncpendmet0515","volume":"3","author":"JR Seckl","year":"2007","unstructured":"Seckl JR, Holmes MC (2007) Mechanisms of disease: glucocorticoids, their placental metabolism and fetal \u201cprogramming\u201d of adult pathophysiology. Nat Clin Pract Endocrinol Metab 3(6):479\u2013488. https:\/\/doi.org\/10.1038\/ncpendmet0515","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"2","key":"6985_CR49","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/apha.12187","volume":"210","author":"EC Cottrell","year":"2014","unstructured":"Cottrell EC, Seckl JR, Holmes MC, Wyrwoll CS (2014) Foetal and placental 11\u03b2-HSD2: a hub for developmental programming. Acta Physiol (Oxf) 210(2):288\u2013295. https:\/\/doi.org\/10.1111\/apha.12187","journal-title":"Acta Physiol (Oxf)"},{"key":"6985_CR50","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jpeds.2018.10.033","volume":"206","author":"D Ley","year":"2019","unstructured":"Ley D, Hallberg B, Hansen-Pupp I et al (2019) rhIGF-1\/rhIGFBP-3 in preterm infants: a phase 2 randomized controlled trial. J Pediatr 206:56-65.e8. https:\/\/doi.org\/10.1016\/j.jpeds.2018.10.033","journal-title":"J Pediatr"},{"key":"6985_CR51","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ghir.2017.08.004","volume":"36","author":"I Hansen-Pupp","year":"2017","unstructured":"Hansen-Pupp I, Hellstr\u00f6m A, Hamdani M et al (2017) Continuous longitudinal infusion of rhIGF-1\/rhIGFBP-3 in extremely preterm infants: evaluation of feasibility in a phase II study. Growth Horm IGF Res 36:44\u201351. https:\/\/doi.org\/10.1016\/j.ghir.2017.08.004","journal-title":"Growth Horm IGF Res"},{"key":"6985_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ghir.2019.11.001","volume":"50","author":"S Klevebro","year":"2020","unstructured":"Klevebro S, Hellgren G, Hansen-Pupp I et al (2020) Elevated levels of IL-6 and IGFBP-1 predict low serum IGF-1 levels during continuous infusion of rhIGF-1\/rhIGFBP-3 in extremely preterm infants. Growth Horm IGF Res 50:1\u20138. https:\/\/doi.org\/10.1016\/j.ghir.2019.11.001","journal-title":"Growth Horm IGF Res"},{"issue":"4","key":"6985_CR53","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1530\/EJE-14-0419","volume":"171","author":"RB Jensen","year":"2014","unstructured":"Jensen RB, Thankamony A, O\u2019Connell SM et al (2014) A randomised controlled trial evaluating IGF1 titration in contrast to current GH dosing strategies in children born small for gestational age: the North European Small-for-Gestational-Age Study. Eur J Endocrinol 171(4):509\u2013518. https:\/\/doi.org\/10.1530\/EJE-14-0419","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"6985_CR54","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1159\/000353438","volume":"80","author":"RB Jensen","year":"2013","unstructured":"Jensen RB, Thankamony A, O\u2019Connell SM et al (2013) Baseline IGF-I levels determine insulin secretion and insulin sensitivity during the first year on growth hormone therapy in children born small for gestational age. Results from a North European Multicentre Study (NESGAS). Horm Res Paediatr 80(1):38\u201346. https:\/\/doi.org\/10.1159\/000353438","journal-title":"Horm Res Paediatr"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-06985-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-06985-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-06985-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T06:02:04Z","timestamp":1780120924000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-06985-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":54,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["6985"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-06985-5","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"313"}}